Biomarkers of Response to Systemic Treatments in FH-deficient RCC

Clinical trial NCT05243173 · UNKNOWN

Trial details

NCT number: NCT05243173
Sponsor: RenJi Hospital
Status: UNKNOWN
Study type: OBSERVATIONAL

Metabolomics Renal Cell Carcinoma FH-Deficient RCC Systemic Treatments

Start date: 2022-05-25
Primary completion: 2024-06-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.